Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Regulation of pancreatic cancer therapy resistance by chemokines

Seminars in Cancer Biology(2022)10.1016/j.semcancer.2022.08.010Source: DataRank Database

Regulation of pancreatic cancer therapy resistance by chemokines is a research paper published in Seminars in Cancer Biology (2022). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 2.14)OA: greenTopics (25)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Soumi Basu ORCID,Abhijit Aithal ORCID,Nidhi V. Dwivedi ORCID,Mansi Gulati,Maneesh Jain ORCID

Live enrichment

PubMed:36064086 PMC:PMC10370390 OpenAlex:https://openalex.org/W4294190610

NCI NIH HHS

Grant: U01 CA210240

NIDDK NIH HHS

Grant: R44 DK117472

NCI NIH HHS

Grant: P01 CA217798

NCI NIH HHS

Grant: R01 CA247471

NCI NIH HHS

Grant: R01 CA195586

NCI NIH HHS

Grant: U01 CA200466

NCI NIH HHS

Grant: U01 CA213862

FWCI

2.14

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10370390/pdf/nihms-1895400.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1044579X22001961?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1044579X22001961?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10370390

Fields of Study

Pancreatic and Hepatic Oncology ResearchPhagocytosis and Immune RegulationCancer Immunotherapy and Biomarkers

MeSH Terms

HumansPancreatic NeoplasmsChemokinesDrug Resistance, NeoplasmCarcinoma, Pancreatic DuctalTumor Microenvironment

Keywords

ChemokineImmunotherapyTumor microenvironmentMedicineMetastasisPancreatic cancerCancer researchImmunologyCancerImmune systemChemokine receptorInternal medicineimmunosuppressionPancreatic Ductal AdenocarcinomaTherapy ResistanceChemokine-signaling

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer

10.6084/m9.figshare.22671566.v1figshare

Additional file 1 of Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer

10.6084/m9.figshare.22671566figshare

Regulation of pancreatic cancer therapy resistance by chemokines

FAIR Checklist

Authors (6)

Funding (7 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)